These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6703984)

  • 1. Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
    Hart WM; Burde RM; Johnston GP; Drews RC
    Arch Ophthalmol; 1984 Mar; 102(3):377-80. PubMed ID: 6703984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term course of chloroquine retinopathy after cessation of medication.
    Brinkley JR; Dubois EL; Ryan SJ
    Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of Amsler grids in early chloroquine retinopathy.
    Easterbrook M
    Ophthalmology; 1984 Nov; 91(11):1368-72. PubMed ID: 6514305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF; Bhargava SK; Rosen ES
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.
    Cabral RTS; Klumb EM; Couto MINN; Carneiro S
    Arq Bras Oftalmol; 2019; 82(1):12-17. PubMed ID: 30403262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variability of chloroquine and hydroxychloroquine retinopathy among various ethnicities].
    Giocanti-Aurégan A; Couturier A; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
    J Fr Ophtalmol; 2018 Apr; 41(4):363-367. PubMed ID: 29678344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine retinopathy.
    Weiner A; Sandberg MA; Gaudio AR; Kini MM; Berson EL
    Am J Ophthalmol; 1991 Nov; 112(5):528-34. PubMed ID: 1951589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic methods for chloroquine diphosphate induced retinopathy in systemic lupus erythematosus].
    Rodrigues LD; Shinjo SK; Oyamada MK; Serracarbassa PD; Takahashi WY; Borba EF; Bonfá ES; Nakashima Y
    Arq Bras Oftalmol; 2009; 72(3):313-20. PubMed ID: 19668959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
    Tanga L; Centofanti M; Oddone F; Parravano M; Parisi V; Ziccardi L; Kroegler B; Perricone R; Manni G
    Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):715-21. PubMed ID: 21253758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RE: Author reply:
    Martínez-Costa L; Trentini FJ; Ibañez MV; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
    Can J Ophthalmol; 2014 Jun; 49(3):308. PubMed ID: 24862783
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
    Martínez-Costa L; Victoria Ibañez M; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
    Can J Ophthalmol; 2013 Oct; 48(5):400-5. PubMed ID: 24093187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RE: Microperimetry and the diagnosis of antimalarial maculopathy.
    Easterbrook M
    Can J Ophthalmol; 2014 Jun; 49(3):307-8. PubMed ID: 24862782
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.